GENECHEM
GeneChem fund and the changing landscape of the genomics industry, the principals set out to raise their second focused fund, GeneChem Therapeutics Venture Fund L.P.. With committed capital of $136.5 million, the Therapeutics Fund's objectives were to invest within the genomics industry but specifically in companies developing therapeutics for proliferative disorders including cancer, infectious diseases, inflammation and diabetes.
GENECHEM
Industry:
Genetics
Founded:
1997-01-01
Status:
Active
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF LetsEncrypt Apache Mobile Non Scaleable Content Microsoft Exchange Online Office 365 Mail Google Maps Microsoft Azure DNS
Current Employees Featured
Fabienne Perreau Administrative Assistant @ GeneChem
Administrative Assistant
Martial Lacroix General Partner @ GeneChem
General Partner
Inès Holzbaur General Partner @ GeneChem
General Partner
John Clement General Partner @ GeneChem
General Partner
Patricia Laplante Project Manager @ GeneChem
Project Manager
Elizabeth Douville General Partner @ GeneChem
General Partner
Maxime Pesant Vice-President, Finance @ GeneChem
Vice-President, Finance
Kevin McBride Project Manager @ GeneChem
Project Manager
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2008-09-03 | Osprey Pharmaceuticals USA | GeneChem investment in Series A - Osprey Pharmaceuticals USA | 11 M USD |
| 2007-11-14 | Ambit Biosciences | GeneChem investment in Series D - Ambit Biosciences | 49.3 M USD |
| 2007-01-30 | Osprey Pharmaceuticals USA | GeneChem investment in Venture Round - Osprey Pharmaceuticals USA | 9 M USD |
| 2007-01-18 | Cytochroma | GeneChem investment in Series C - Cytochroma | 21 M CAD |
| 2006-12-01 | Xanthus Pharmaceuticals | GeneChem investment in Series B - Xanthus Pharmaceuticals | 25 M USD |
| 2005-05-12 | Ambit Biosciences | GeneChem investment in Series C - Ambit Biosciences | 31 M USD |
| 2004-04-27 | NewBiotics | GeneChem investment in Series E - NewBiotics | 4.57 M USD |
| 2003-12-12 | Xanthus Pharmaceuticals | GeneChem investment in Series B - Xanthus Pharmaceuticals | 30.8 M USD |
| 2003-07-03 | LymphoSign | GeneChem investment in Series A - LymphoSign | 5.9 M USD |
| 2002-12-09 | Idun Pharmaceuticals | GeneChem investment in Series A - Idun Pharmaceuticals | 22.8 M USD |
More informations about "GeneChem"
GeneChem - Crunchbase Company Profile & Funding
GeneChem Inc. is specialized in the development of health-related substances such as functional oligosaccharides, new bio-medicines, and gene therapy …See details»
GeneChem - Crunchbase Investor Profile & Investments
GeneChem fund and the changing landscape of the genomics industry, the principals set out to raise their second focused fund, GeneChem Therapeutics Venture Fund L.P.. With committed capital of $136.5 million, the Therapeutics …See details»
GeneChem - Venbridge
GeneChem is a manager of focused biotechnology venture capital funds. We have over $350M in assets distributed over four funds: GeneChem Technologies, GeneChem Therapeutics, Agechem and AmorChem. Since 1997, GeneChem …See details»
Genechem (China) - Crunchbase Company Profile
Genechem (China) closed its last funding round on Apr 3, 2020 from a Series C round. Who are Genechem (China) 's competitors? Alternatives and possible …See details»
Genechem - 2025 Company Profile, Funding & Competitors - Tracxn
Genechem - Products and services in molecular biology. Raised a total funding of $56.4M over 2 rounds from 4 investors. Founded by Honghua Qu in the year 2002. Genechem has 857 …See details»
GeneChem Inc. - LinkedIn
GeneChem has developed health-related functional materials and innovative drugs such as functional oligosaccharides, new bio-drugs and gene therapy based on nucleic acid chemistry, phosphate ...See details»
Genechem - VentureRadar
Founded in 2002, now with over 500 employees, Genechem works closely with Research Oncologists to translate clinical research into therapeutics addressing high clinical unmet …See details»
Gene Chem Company Profile 2024: Valuation, Funding …
Gene Chem General Information Description. Provider of disease and genetic research services. The company focuses on the research and development of genetic diseases and develops innovative drugs for cancer treatment, …See details»
GeneChem investment portfolio - PitchBook
GeneChem General Information Company Description. Founded in 1997, GeneChem is a venture capital firm based in Montreal, Canada. The firm seeks to invest in United States, Canada, and …See details»
GeneChem Company Profile | Westmount, QC, Canada
GeneChem Company Profile | Westmount, QC, Canada | Competitors, Financials & Contacts - Dun & BradstreetSee details»
GeneChem Management - Private Equity International
GeneChem Management. News, insights, analysis and data. GeneChem Management overview. Established in 1997, GeneChem Management was a Canada-based private equity firm, …See details»
Shanghai Genchem Co., Ltd. (Genechem) Announces Global
SHANGHAI, April 6,, 2021 /PRNewswire/ -- Shanghai Genechem Co., Ltd. (Genechem), a discovery company dedicated to novel drug target discovery and development of novel …See details»
GeneChem - Investments, Portfolio & Company Exits - Crunchbase
GeneChem 's most notable exits include Lexicon Pharmaceuticals, Triad Life Sciences, and Idun Pharmaceuticals. Which industries has this organization had the most exits in? ShowSee details»
GeneChem - Investor in Montreal, Quebec - Ask For Funding
GeneChem is a manager of focused biotechnology venture capital funds. We have over $350M in assets distributed over four funds: GeneChem Technologies, GeneChem Therapeutics, …See details»
Genechem | VentureRadar
Founded in 2002, now with over 500 employees, Genechem works closely with Research Oncologists to translate clinical research into therapeutics addressing high clinical unmet …See details»
GeneChem - Funding, Financials, Valuation & Investors - Crunchbase
Nov 16, 2007 GeneChem has made 3 investments. Their most recent investment was on Nov 16, 2007 , when BioVex raised $35M . How many investments has this organization made …See details»
[PRNewswire] Shanghai Genechem Co., Ltd. (Genechem) …
Apr 7, 2021 Genechem is a leading innovation research company focused on target discovery/validation, development of antibody and cell therapy products against novel targets, …See details»
Shanghai Genechem Co., Ltd. (Genechem) Announces Global …
SHANGHAI, April 6, 2021 /PRNewswire/ -- Shanghai Genechem Co., Ltd. (Genechem), a discovery company dedicated to novel drug target discovery and development of novel …See details»
Shanghai Genechem Co., Ltd. (Genechem) Announces Global …
Apr 6, 2021 Shanghai Genechem Co., Ltd. (Genechem), a discovery company dedicated to novel drug target discovery and development of novel therapeutics, announced the execution …See details»
GeneChem - Contacts, Employees, Board Members, Advisors
GeneChem fund and the changing landscape of the genomics industry, the principals set out to raise their second focused fund, GeneChem. Search Crunchbase. Start Free Trial . Chrome …See details»